• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS

    1/29/25 5:15:00 PM ET
    $CLB
    Oilfield Services/Equipment
    Energy
    Get the next $CLB alert in real time by email
    • FOURTH QUARTER REVENUE OF $129.2 MILLION, DOWN 4% SEQUENTIALLY AND UP SLIGHTLY YEAR-OVER-YEAR
    • FOURTH QUARTER OPERATING INCOME OF $14.2 MILLION; EX-ITEMS, $15.7 MILLION, DOWN 14% SEQUENTIALLY, UP 4% YEAR-OVER-YEAR
    • FOURTH QUARTER OPERATING MARGINS, EX-ITEMS, OF 12% 
    • FOURTH QUARTER GAAP EPS OF $0.15; EX-ITEMS, $0.22, DOWN 12% SEQUENTIALLY, UP 16% YEAR-OVER-YEAR
    • FOURTH QUARTER FREE CASH FLOW OF $16.2 MILLION, UP OVER 50% SEQUENTIALLY 
    • DEBT LEVERAGE RATIO REDUCED TO 1.31, AND NET DEBT REDUCED BY $11.7 MILLION
    • COMPANY REPURCHASED 264,982 SHARES OF COMMON STOCK, A VALUE OF $4.9 MILLION, DURING THE FOURTH QUARTER
    • COMPANY ANNOUNCES Q1 2025 QUARTERLY DIVIDEND



    • FULL YEAR REVENUE OF $523.8 MILLION, UP 3%
    • FULL YEAR OPERATING INCOME OF $58.6 MILLION; EX-ITEMS, $65.3 MILLION, UP 7%
    • FULL YEAR GAAP EPS OF $0.66; EX-ITEMS, EPS OF $0.87, UP 9%
    • FULL YEAR FREE CASH FLOW OF $43.4 MILLION, UP OVER 200% COMPARED TO 2023

    HOUSTON, Jan. 29, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported fourth quarter 2024 revenue of $129,200,000. Core's operating income was $14,200,000, with diluted earnings per share ("EPS") of $0.15, all in accordance with U.S. generally accepted accounting principles ("GAAP"). Operating income, ex-items, a non-GAAP financial measure, was $15,700,000, yielding operating margins of 12%, and EPS, ex-items, of $0.22. For the full year 2024, revenue of $523,800,000 was up 3% compared to 2023, generating operating income, ex-items, of $65,300,000 with incremental margins of 29%. The Company's full year EPS, ex-items, was $0.87, representing year-over-year growth of 9%. A full reconciliation of non-GAAP financial measures is included in the attached financial tables.

    Core Laboratories logo (PRNewsFoto/Core Laboratories) (PRNewsfoto/Core Laboratories)

    Core's CEO, Larry Bruno stated, "Our full year financial results delivered improvements in revenue, operating income, operating margins, free cash flow and earnings per share. Our performance was driven by resilient demand for our Reservoir Description services which continued to grow across our international laboratory network despite headwinds from reduced U.S. land activity and disruptions caused by on-going geopolitical conflicts and associated sanctions. Core's investments to expand capabilities in the Middle East are now yielding returns. While Production Enhancement experienced higher international product sales and increased demand for Core's completion diagnostic services, full year financial performance was adversely impacted by lower levels of onshore well completions in the U.S. compared to 2023. The Company also continued to strengthen its balance sheet by reducing debt. As of December 31, 2024, our debt leverage ratio was reduced to 1.31, the lowest it has been in over eight years. Core remains focused on executing its strategic business priorities which include further reduction of debt and strengthening the balance sheet. In addition, we will remain active in pursuit of growth opportunities and maintain our long-standing practice of returning excess free cash to our shareholders, as we did in the fourth quarter through a combination of share buybacks and our quarterly dividend."

    Reservoir Description

    Reservoir Description operations are closely correlated with trends in international and offshore activity levels, with approximately 80% of revenue sourced from projects originating outside the U.S. Revenue in the fourth quarter of 2024 was $86,800,000, down 2% sequentially, however, up 3% from last year. Operating income on a GAAP basis was $16,600,000, while operating income, ex-items, was $14,100,000, yielding operating margins over 16%, expanding 170 basis points, year-over-year. The segment's financial performance in the fourth quarter was adversely impacted by a sequential decline in U.S. land activity, as well as on-going international geopolitical conflicts and associated sanctions. These factors were somewhat offset by continued growth in demand for reservoir rock and fluid analysis in several international regions. For the full year 2024, the segment's revenue of $346,100,000 increased 4%, generating operating income, ex-items, of $52,800,000 with incremental margins over 58%.

    In the fourth quarter of 2024, Core Lab completed a laboratory study for a Middle Eastern National Oil Company ("NOC") that utilized Core's proprietary Nuclear Magnetic Resonance ("NMR") technologies. The study combined 2D High Frequency and Low Frequency NMR instrumentation to investigate the reservoir rocks at varying temperatures. By utilizing multiple NMR frequencies and other proprietary technologies, Core's scientists were able to differentiate liquid (potentially movable) from solid (immovable) hydrocarbon phases in the rock samples. This critical distinction is often very difficult to determine from traditional down-hole log analysis techniques. Without the analytical results and interpretations provided by Core Lab, the NOC might have overestimated recoverable reserves in the target stratigraphic horizon.

    Production Enhancement

    Production Enhancement operations, which are focused on complex completions in unconventional oil and gas reservoirs in the U.S., as well as conventional and unconventional projects across the globe, posted fourth quarter 2024 revenue of $42,400,000, down 7% sequentially and 3% year-over-year. Operating loss on a GAAP basis was $(2,600,000), while operating income, ex-items, was $1,500,000, yielding operating margins of 4%. The sequential and year-over-year decline in revenue reflects lower U.S. onshore completion activity which resulted in a decline in product sales. However, improved demand for completion diagnostic services and international product sales somewhat offset the soft U.S. onshore market. For the full year 2024, the segment's revenue of $177,700,000 was comparable to full year 2023, despite the decrease in U.S. onshore well completion activity.

    In the fourth quarter of 2024, Core Lab collaborated with a leading oilfield services company operating in Southeast Asia to improve productivity from a low permeability gas reservoir. The Company's Production Enhancement team deployed the Company's proprietary STIMGUNTM propellant technology to improve hydrocarbon flow from the reservoir. Core's approach combined conventional perforating energetics with even higher energy STIMGUNTM propellant stimulation to achieve improved near-well bore permeability. When activated, STIMGUNTM releases an engineered, sequenced, and controlled burst of energy that creates fracture networks inside the rock formation, adjacent to the perforation tunnels. This international project, which employed more than 1,200 feet of STIMGUNTM, resulted in a 55% increase in expected natural gas production, highlighting the exceptional performance of Core's proprietary completion technology.

    Also in the fourth quarter of 2024, Core Lab was engaged by an operator in Canada to determine oil flow from conventional wells where a single vertical borehole had multiple horizontal legs. The operator wanted to identify which legs were contributing oil production to the vertical borehole. By placing unique, engineered, solid particle FlowProfiler™ oil tracers into each horizontal leg, the operator was able to confirm oil production from 87% of the traced legs after thirty days of flow. As an enhancement to this service, Core Lab has recently introduced FlowProfiler™ water tracers, which will allow operators to determine both water and oil production from each of the horizontal legs.

    Liquidity, Free Cash Flow, Share Repurchases, and Dividend

    Core continues to focus on maximizing free cash flow ("FCF"), a non-GAAP financial measure defined as cash from operations less capital expenditures. For the fourth quarter of 2024, cash from operations was $20,600,000 and capital expenditures were $4,400,000, yielding FCF of $16,200,000. The Company generated $43,400,000 of FCF for the twelve months ending December 31, 2024, an improvement of over 200% compared to full year 2023. The year-over-year improvement in FCF reflects higher profitability, as well as better management of inventory and working capital.

    In the fourth quarter, Core Lab used a portion of this FCF to repurchase 264,982 shares at an aggregate purchase price of $4,900,000.

    As of December 31, 2024, Core's net debt (defined as long-term debt less cash and cash equivalents) was $108,800,000, which was reduced by $11,700,000 during the quarter and by $42,000,000 for the full year. The Company's leverage ratio (calculated as total net debt divided by adjusted EBITDA for the last four quarters) was reduced to 1.31 as of December 31, 2024, which improved from 1.47 as of September 30, 2024.

    Core expects to continue generating positive FCF in future quarters. The Company will remain focused on executing its strategic business initiatives while also further reducing its leverage ratio. In addition, Core Lab will continue to evaluate allocation of capital and other uses of free cash.

    On October 23, 2024, Core's Board of Directors ("Board") announced a quarterly cash dividend of $0.01 per share of common stock, which was paid on November 25, 2024, to shareholders of record on November 4, 2024.

    On January 29, 2025, the Board approved a cash dividend of $0.01 per share of common stock payable on March 3, 2025, to shareholders of record on February 10, 2025. 

    Return On Invested Capital

    The Board and the Company's Executive Management continue to focus on strategies that maximize return on invested capital ("ROIC") and FCF, factors that have high correlation to total shareholder return. Core's commitment to an asset-light business model and disciplined capital stewardship promote capital efficiency and are designed to produce more predictable and superior long-term ROIC.

    The Board has established an internal metric to demonstrate ROIC performance relative to the oilfield service companies listed as Core's Comp Group by Bloomberg, as the Company continues to believe superior ROIC will result in higher total shareholder return. Using Bloomberg's formula, the Company's ROIC for the fourth quarter of 2024 improved to 10.3%.

    Industry and Core Lab Outlook and Guidance

    As 2025 unfolds, Core will continue to execute its strategic plan of technology investments targeted to both solve client problems and capitalize on Core's growth opportunities. A cautious near-term approach was adopted by operators in the back half of 2024, driven by concerns over a potential imbalance between crude oil supply and demand. However, Core maintains its constructive long-term outlook on international upstream projects for 2025 and beyond. The IEA, EIA and OPEC+ continue to forecast growth in crude oil demand between approximately 1.1 and 1.4 million barrels per day for 2025, which is in addition to the natural decline of production from existing fields. As such, continued investment in the development of onshore and offshore crude oil fields will be required to meet demand.

    In the near term, the Company expects that crude oil markets will remain volatile due to global economic uncertainties and geopolitical risks. In January of 2025, expanded sanctions 1) impacted the maritime movement and trading of crude oil and derived products, along with the demand for necessary laboratory assay work, and 2) prohibited product sales and services to a broader group of entities.

    In alignment with this outlook, Core will remain well-engaged on long-cycle international projects. Looking ahead, as international project activity is expected to be steady, committed long-term upstream projects from the South Atlantic Margin, North and West Africa, Norway, the Middle East, and certain areas of Asia Pacific support mid-single digit year-over-year growth in demand for Core Lab's services and products. In the U.S., onshore activity is projected to be flat to slightly down compared to 2024.

    In addition to the geopolitical risks and recently expanded sanctions, Core expects typical sequential seasonal industry patterns will cause activity in the first quarter of 2025 to decline in some regions. Severe weather in the U.S. and Mediterranean regions resulted in suspended client activities and facility closures. As such, Core projects Reservoir Description's first quarter revenue to range from $82,000,000 to $85,000,000, with operating income of $9,000,000 to $10,700,000. For the first quarter 2025, onshore U.S. drilling and completion activity was adversely impacted by freezing conditions and continued to decline throughout January; however, activity is expected to improve as the quarter unfolds. Consequently, Production Enhancement's first quarter revenue is expected to range from $39,000,000 to $42,000,000, with operating income of $1,100,000 to $2,000,000.

    The Company's first quarter 2025 revenue is projected to range from $121,000,000 to $127,000,000, with operating income of $10,200,000 to $12,800,000, yielding operating margins of approximately 9%. Core's effective tax is projected at approximately 25% for 2025. This change in the effective tax rate is projected to increase income tax expense for the first quarter of 2025 by approximately $500,000. As such, EPS for the first quarter of 2025 is expected to be $0.12 to $0.16.

    The Company's first quarter 2025 guidance is based on projections for underlying operations and excludes gains and losses in foreign exchange.

    Earnings Call Scheduled

    The Company has scheduled a conference call to discuss Core's fourth quarter and full year 2024 earnings announcement. The call will begin at 7:30 a.m. CDT / 8:30 a.m. EDT on Thursday, January 30, 2025. To register for the listen-only webcast, log on to www.corelab.com 15 minutes before the start of the call. For those not available to listen to the live webcast, a replay and transcript will be available on the Company's website shortly after the call. Analysts may contact [email protected] for conference call dial-in information.

    Core Laboratories Inc. is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance. The Company has over 70 offices in more than 50 countries and is located in every major oil-producing province in the world. This release, as well as other statements we make, includes forward-looking statements regarding the Company's future revenue, profitability, business strategies and developments, demand for the Company's products and services and for products and services of the oil and gas industry generally, made in reliance upon the safe harbor provisions of Federal securities law. The Company's outlook is subject to various important cautionary factors, including risks and uncertainties related to the oil and natural gas industry, business and general economic conditions, including inflationary pressures, the ability to achieve the benefits of the redomestication of the parent company from the Netherlands to the United States, international markets, international political climates, including the Russia-Ukraine and the Middle East geopolitical conflicts, public health crises, and any related actions taken by businesses and governments, and other factors as more fully described in the Company's most recent Forms 10-K, 10-Q and 8-K filed with or furnished to the U.S. Securities and Exchange Commission. These important factors could cause the Company's actual results to differ materially from those described in these forward-looking statements. Such statements are based on current expectations of the Company's performance and are subject to a variety of factors, some of which are not under the control of the Company. Because the information herein is based solely on data currently available, and because it is subject to change as a result of changes in conditions over which the Company has no control or influence, such forward-looking statements should not be viewed as assurance regarding the Company's future performance.

    The Company undertakes no obligation to publicly update or revise any forward-looking statement to reflect events or circumstances that may arise after the date of this press release, except as required by law.

    Visit the Company's website at www.corelab.com.

    CORE LABORATORIES INC. & SUBSIDIARIES

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

    (In thousands, except per share data)

    (Unaudited)







    Quarter Ended





    % Variance





    December 31,

    2024





    September 30,

    2024





    December 31,

    2023





    vs. Q3-2024



    vs. Q4-2023

    REVENUE



    $

    129,237





    $

    134,397





    $

    128,210





    (3.8) %



    0.8 %





























    OPERATING EXPENSES:



























    Costs of services and product sales





    106,199







    106,805







    101,517





    (0.6) %



    4.6 %

    General and administrative expense





    9,080







    8,642







    8,665





    5.1 %



    4.8 %

    Depreciation and amortization





    3,664







    3,676







    3,874





    (0.3) %



    (5.4) %

    Other (income) expense, net





    (3,880)







    (4,529)







    (427)





    NM



    NM

    Total operating expenses





    115,063







    114,594







    113,629





    0.4 %



    1.3 %





























    OPERATING INCOME





    14,174







    19,803







    14,581





    (28.4) %



    (2.8) %

    Interest expense





    2,629







    3,108







    3,618





    (15.4) %



    (27.3) %

    Income before income taxes





    11,545







    16,695







    10,963





    (30.8) %



    5.3 %

    Income tax expense





    4,076







    4,691







    8,529





    (13.1) %



    (52.2) %

    Net income





    7,469







    12,004







    2,434





    (37.8) %



    206.9 %

    Net income attributable to non-

       controlling interest





    66







    259







    235





    NM



    NM

    Net income attributable to Core

       Laboratories Inc.



    $

    7,403





    $

    11,745





    $

    2,199





    (37.0) %



    236.7 %





























    Diluted earnings per share



    $

    0.16





    $

    0.25





    $

    0.05





    (36.0) %



    220.0 %





























    Diluted earnings per share

    attributable to Core Laboratories

    Inc.



    $

    0.15





    $

    0.25





    $

    0.05





    (40.0) %



    200.0 %





























    Diluted weighted average common

    shares outstanding





    47,773







    47,820







    47,557





    (0.1) %



    0.5 %





























    Effective tax rate





    35

    %





    28

    %





    78

    %



    NM



    NM





























    SEGMENT INFORMATION:























































    Revenue:



























    Reservoir Description



    $

    86,793





    $

    88,840





    $

    84,628





    (2.3) %



    2.6 %

    Production Enhancement





    42,444







    45,557







    43,582





    (6.8) %



    (2.6) %

    Total



    $

    129,237





    $

    134,397





    $

    128,210





    (3.8) %



    0.8 %





























    Operating income:



























    Reservoir Description



    $

    16,643





    $

    16,487





    $

    12,259





    0.9 %



    35.8 %

    Production Enhancement





    (2,597)







    3,232







    2,195





    (180.4) %



    (218.3) %

    Corporate and Other





    128







    84







    127





    NM



    NM

    Total



    $

    14,174





    $

    19,803





    $

    14,581





    (28.4) %



    (2.8) %





























    "NM" means not meaningful



























     

    CORE LABORATORIES INC. & SUBSIDIARIES

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

    (In thousands, except per share data)

    (Unaudited)







    Year Ended December 31,





    % Variance





    2024





    2023







    REVENUE



    $

    523,848





    $

    509,790





    2.8 %



















    OPERATING EXPENSES:

















    Costs of services and product sales





    420,522







    399,957





    5.1 %

    General and administrative expense





    39,770







    40,259





    (1.2) %

    Depreciation and amortization





    14,953







    15,784





    (5.3) %

    Other (income) expense, net





    (9,953)







    (850)





    NM

    Total operating expenses





    465,292







    455,150





    2.2 %



















    OPERATING INCOME





    58,556







    54,640





    7.2 %

    Interest expense





    12,369







    13,430





    (7.9) %

    Income before income taxes





    46,187







    41,210





    12.1 %

    Income tax expense





    14,034







    4,185





    235.3 %

    Net income





    32,153







    37,025





    (13.2) %

    Net income attributable to non-controlling interest





    753







    350





    NM

    Net income attributable to Core Laboratories Inc.



    $

    31,400





    $

    36,675





    (14.4) %



















    Diluted earnings per share



    $

    0.67





    $

    0.78





    (14.1) %



















    Diluted earnings per share attributable to Core Laboratories Inc.



    $

    0.66





    $

    0.77





    (14.3) %



















    Diluted weighted average common shares outstanding





    47,685







    47,523





    0.3 %



















    Effective tax rate





    30

    %





    10

    %



    NM



















    SEGMENT INFORMATION:



































    Revenue:

















    Reservoir Description



    $

    346,146





    $

    333,345





    3.8 %

    Production Enhancement





    177,702







    176,445





    0.7 %

    Total



    $

    523,848





    $

    509,790





    2.8 %



















    Operating income:

















    Reservoir Description



    $

    51,466





    $

    41,039





    25.4 %

    Production Enhancement





    6,612







    12,519





    (47.2) %

    Corporate and Other





    478







    1,082





    (55.8) %

    Total



    $

    58,556





    $

    54,640





    7.2 %



















    "NM" means not meaningful

















     

    CORE LABORATORIES INC. & SUBSIDIARIES

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (In thousands)

    (Unaudited) 

























    % Variance

    ASSETS:



    December 31,

    2024





    September 30,

    2024





    December 31,

    2023





    vs. Q3-2024



    vs. Q4-2023





























    Cash and cash equivalents



    $

    19,157





    $

    21,474





    $

    15,120





    (10.8) %



    26.7 %

    Accounts receivable, net





    111,761







    117,591







    109,352





    (5.0) %



    2.2 %

    Inventories





    59,402







    65,490







    71,702





    (9.3) %



    (17.2) %

    Other current assets





    36,286







    30,672







    26,962





    18.3 %



    34.6 %

    Total current assets





    226,606







    235,227







    223,136





    (3.7) %



    1.6 %





























    Property, plant and equipment, net





    97,063







    97,606







    99,626





    (0.6) %



    (2.6) %

    Right of use assets





    56,488







    56,650







    53,842





    (0.3) %



    4.9 %

    Intangibles, goodwill and other long-

    term assets, net





    210,249







    210,983







    209,791





    (0.3) %



    0.2 %

    Total assets



    $

    590,406





    $

    600,466





    $

    586,395





    (1.7) %



    0.7 %





























    LIABILITIES AND EQUITY:























































    Accounts payable



    $

    34,549





    $

    33,627





    $

    33,506





    2.7 %



    3.1 %

    Operating lease liabilities





    10,690







    11,435







    10,175





    (6.5) %



    5.1 %

    Other current liabilities





    52,347







    49,876







    44,416





    5.0 %



    17.9 %

    Total current liabilities





    97,586







    94,938







    88,097





    2.8 %



    10.8 %





























    Long-term debt, net





    126,111







    139,872







    163,134





    (9.8) %



    (22.7) %

    Long-term operating lease liabilities





    43,343







    43,727







    42,076





    (0.9) %



    3.0 %

    Other long-term liabilities





    65,629







    65,508







    63,281





    0.2 %



    3.7 %





























    Total equity





    257,737







    256,421







    229,807





    0.5 %



    12.2 %

    Total liabilities and equity



    $

    590,406





    $

    600,466





    $

    586,395





    (1.7) %



    0.7 %

     

    CORE LABORATORIES INC. & SUBSIDIARIES

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (In thousands)

    (Unaudited)







    Year Ended December 31,







    2024





    2023



    CASH FLOWS FROM OPERATING ACTIVITIES:













    Net income



    $

    32,153





    $

    37,025



    Adjustments to reconcile net income to net cash provided by operating activities:













    Stock-based compensation





    3,755







    13,971



    Depreciation and amortization





    14,953







    15,784



    Deferred income taxes





    674







    (10,811)



    Accounts receivable





    (3,612)







    (2,618)



    Inventories





    9,367







    (12,976)



    Accounts payable





    519







    (12,878)



    Other adjustments to net income





    (1,421)







    (2,708)



    Net cash provided by operating activities





    56,388







    24,789

















    CASH FLOWS FROM INVESTING ACTIVITIES:













    Capital expenditures





    (13,028)







    (10,579)



    Net proceeds from life insurance policies and from insurance recovery





    4,878







    3,375



    Other investing activities





    1,756







    552



    Net cash used in investing activities





    (6,394)







    (6,652)

















    CASH FLOWS FROM FINANCING ACTIVITIES:













    Repayment of long-term debt





    (82,000)







    (211,000)



    Proceeds from long-term debt





    44,000







    202,000



    Equity related transaction costs





    (756)







    (4,068)



    Dividends paid





    (1,876)







    (1,868)



    Repurchase of common stock





    (5,306)







    (2,202)



    Other financing activities





    (19)







    (1,307)



    Net cash used in financing activities





    (45,957)







    (18,445)

















    NET CHANGE IN CASH AND CASH EQUIVALENTS





    4,037







    (308)



    CASH AND CASH EQUIVALENTS, beginning of year





    15,120







    15,428



    CASH AND CASH EQUIVALENTS, end of year



    $

    19,157





    $

    15,120



    Non-GAAP Information

    Management believes that the exclusion of certain income and expenses enables it to evaluate more effectively the Company's operations period-over-period and to identify operating trends that could otherwise be masked by the excluded Items. For this reason, management uses certain non-GAAP measures that exclude these Items and believes that this presentation provides a clearer comparison with the results reported in prior periods. The non-GAAP financial measures should be considered in addition to, and not as a substitute for, the financial results prepared in accordance with GAAP, as more fully discussed in the Company's financial statements and filings with the Securities and Exchange Commission.

    Reconciliation of Operating Income, Net Income and Diluted Earnings Per Share Attributable to

    Core Laboratories Inc.

    (In thousands, except per share data)

    (Unaudited)







    Operating Income







    Quarter Ended







    December 31,

    2024





    September 30,

    2024





    December 31,

    2023



    GAAP reported



    $

    14,174





    $

    19,803





    $

    14,581



    Stock compensation (1)





    (771)







    (1,364)







    —



    Inventory and asset write-downs, lease abandonment and severance (2)





    4,115







    —







    —



    Gain on insurance recovery (3)





    (2,572)







    —







    —



    Foreign exchange losses (gains)





    761







    (239)







    468



    Excluding specific items



    $

    15,707





    $

    18,200





    $

    15,049











    Net Income Attributable to Core Laboratories Inc.





    Quarter Ended





    December 31,

    2024



    September 30,

    2024



    December 31,

    2023

    GAAP reported



    $7,403



    $11,745



    $2,199

    Stock compensation (1)



    (617)



    (1,091)



    —

    Inventory and asset write-downs, lease abandonment and severance (2)



    3,292



    —



    —

    Gain on insurance recovery (3)



    (2,058)



    —



    —

    Foreign exchange losses (gains)



    610



    (191)



    374

    Reversal of net deferred tax liabilities and effect of higher (lower) tax rate (4)



    1,766



    1,351



    6,336

    Excluding specific items



    $10,396



    $11,814



    $8,909









    Diluted Earnings Per Share Attributable to Core Laboratories Inc.







    Quarter Ended





    Year ended







    December 31,

    2024





    September 30,

    2024





    December 31,

    2023





    December 31,

    2024



    GAAP reported



    $

    0.15





    $

    0.25





    $

    0.05





    $

    0.66



    Stock compensation (1)





    (0.01)







    (0.02)







    —







    0.02



    Inventory and asset write-downs, lease abandonment

    and severance (2)





    0.07







    —







    —







    0.11



    Gain on insurance recovery (3)





    (0.04)







    —







    —







    (0.04)



    Foreign exchange losses (gains)





    0.01







    (0.01)







    0.01







    0.02



    Reversal of net deferred tax liabilities and effect of

    higher (lower) tax rate (4)





    0.04







    0.03







    0.13







    0.10



    Excluding specific items



    $

    0.22





    $

    0.25





    $

    0.19





    $

    0.87





























    (1) The quarters ended September 30, 2024 and December 31, 2024 include reversals of stock compensation expense previously recognized

    due to a change in probability of performance conditions for certain executives' share awards. The year ended December 31, 2024 includes

    reversals of stock compensation expense previously recognized due to a change in probability of performance conditions for certain executives'

    share awards and the acceleration of stock compensation expense associated with employees reaching eligible retirement age.



    (2) Includes the write-down of leasehold improvements, right of use assets and/or other assets and exit costs associated with consolidation of

    certain facilities.



    (3) Includes gain on insurance recovery associated with the fire incident in one of the Company's U.K. facilities.



    (4) The quarters ended September 30, 2024 and December 31, 2024, and the year ended December 31, 2024, includes the effect to reflect tax

    expense at a normalized rate of 20%. The quarter ended December 31, 2023 includes the reversal of certain net deferred tax liabilities which will

    not be realized as a result of the Company's redomestication from the Netherlands to the United States and the effect to reflect tax expense at a

    normalized rate of 20%.



     

    Segment Information

    (In thousands)

    (Unaudited)







    Operating Income







    Quarter Ended December 31, 2024







    Reservoir

    Description





    Production

    Enhancement





    Corporate and

    Other



    GAAP reported



    $

    16,643





    $

    (2,597)





    $

    128



    Stock compensation (1)





    (489)







    (282)







    —



    Inventory and asset write-downs, lease abandonment and severance (2)





    —







    4,115







    —



    Gain on insurance recovery (3)





    (2,572)







    —







    —



    Foreign exchange losses (gains)





    549







    271







    (59)



    Excluding specific items



    $

    14,131





    $

    1,507





    $

    69



    Return on Invested Capital

    Return on Invested Capital ("ROIC") is presented based on management's belief that this non-GAAP measure is useful information to investors and management when comparing profitability and the efficiency with which capital has been employed over time relative to other companies. The Board has established an internal metric to demonstrate ROIC performance relative to the oilfield service companies listed as Core's Comp Group by Bloomberg. ROIC is not a measure of financial performance under GAAP and should not be considered as an alternative to net income.

    ROIC of 10.3% is defined by Bloomberg as Net Operating Profit After Tax ("NOPAT") of $40.9 million divided by Average Total Invested Capital ("Average TIC") of $397.6 million, where NOPAT is defined as GAAP net income before non-controlling interest plus the sum of income tax expense, interest expense, and pension expense, less pension service cost and tax effect on income before interest and tax expense for the last four quarters. Average TIC is defined as the average of beginning and ending periods' GAAP stockholders' equity, plus the sum of net long-term debt, lease liabilities, allowance for credit losses, net of deferred taxes and income taxes payable.

    Free Cash Flow

    Core uses the non-GAAP financial measure of free cash flow to evaluate its cash flows and results of operations. Free cash flow is defined as net cash provided by operating activities (which is the most directly comparable GAAP measure) less cash paid for capital expenditures. Management believes that free cash flow provides useful information to investors regarding the cash available in the period in excess of Core's needs to fund its capital expenditures and operating activities. Free cash flow is not a measure of operating performance under GAAP and should not be considered in isolation nor construed as an alternative to operating income, net income, or cash flows from operating, investing, or financing activities, each as determined in accordance with GAAP. Free cash does not represent residual cash available for distribution because Core may have other non-discretionary expenditures that are not deducted from the measure. Moreover, since free cash flow is not a measure determined in accordance with GAAP and thus is susceptible to varying interpretations and calculations, free cash flow as presented may not be comparable to similarly titled measures presented by other companies.

    Computation of Free Cash Flow

    (In thousands)

    (Unaudited)







    Quarter Ended





    Year Ended







    December 31, 2024





    December 31, 2024



    Net cash provided by operating activities



    $

    20,615





    $

    56,388



    Capital expenditures





    (4,381)







    (13,028)



    Free cash flow



    $

    16,234





    $

    43,360



     

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/core-lab-reports-fourth-quarter-and-full-year-2024-results-302363701.html

    SOURCE Core Laboratories Inc

    Get the next $CLB alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CLB

    DatePrice TargetRatingAnalyst
    3/12/2025$15.00 → $16.00Sell → Neutral
    Citigroup
    6/30/2023$22.00 → $21.00Neutral → Sell
    Citigroup
    4/18/2023$21.50Neutral → Underperform
    BofA Securities
    1/9/2023Underperform → Neutral
    BofA Securities
    10/7/2022$24.00 → $17.00Sell → Neutral
    Citigroup
    9/26/2022$20.00Equal-Weight → Underweight
    Morgan Stanley
    4/18/2022$19.50 → $21.30Neutral → Underweight
    Piper Sandler
    1/18/2022$32.00 → $30.00Equal-Weight
    Morgan Stanley
    More analyst ratings

    $CLB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Core Laboratories Inc. (Amendment)

      SC 13G/A - CORE LABORATORIES N V (0001000229) (Subject)

      6/12/23 4:02:30 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • SEC Form SC 13G/A filed by Core Laboratories N.V. (Amendment)

      SC 13G/A - CORE LABORATORIES N V (0001000229) (Subject)

      2/14/23 4:08:12 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • SEC Form SC 13G/A filed by Core Laboratories N.V. (Amendment)

      SC 13G/A - CORE LABORATORIES N V (0001000229) (Subject)

      2/14/23 9:10:51 AM ET
      $CLB
      Oilfield Services/Equipment
      Energy

    $CLB
    Financials

    Live finance-specific insights

    See more
    • CORE LAB REPORTS FIRST QUARTER 2025 RESULTS

      REVENUE OF $123.6 MILLION, DOWN 4% SEQUENTIALLY AND 5% YEAR-OVER-YEAROPERATING INCOME OF $4.4 MILLION; EX-ITEMS, $11.8 MILLION, DOWN 25% SEQUENTIALLY AND 21% YEAR-OVER-YEAROPERATING MARGINS, EX-ITEMS, OF 10% GAAP EPS OF $0.00; EX-ITEMS, $0.14, DOWN 35% SEQUENTIALLY, AND 25% YEAR-OVER-YEARFREE CASH FLOW OF $3.9 MILLION, UP OVER 50% YEAR-OVER-YEAR NET DEBT REDUCED BY $4.9 MILLION; DEBT LEVERAGE RATIO REMAINS AT 1.31 COMPANY REPURCHASED 131,598 SHARES OF COMMON STOCK, A VALUE OF $2.0 MILLION COMPANY ANNOUNCES Q1 2025 QUARTERLY DIVIDEND HOUSTON, April 23, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported first quarter 2025 revenue of $123,6

      4/23/25 5:15:00 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • CORE LABORATORIES ANNOUNCES TIMING OF FIRST QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL

      HOUSTON, March 24, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its first quarter 2025 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m. EST on April 24, 2025. Larry Bruno, Chairman and CEO, Chris Hill, CFO, and Gwen Gresham, SVP Corporate Development and Investor Relations, will discuss financial and operational results. An earnings press release will be issued after market close on April 23, 2025, and may be accessed through the Company's website at www.corelab.com. To register for the listen-only webcast, log on to www.corelab.com at least fifteen minutes prior to the start of the call. For those not available to listen to the live webcast, a replay

      3/24/25 4:15:00 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS

      FOURTH QUARTER REVENUE OF $129.2 MILLION, DOWN 4% SEQUENTIALLY AND UP SLIGHTLY YEAR-OVER-YEARFOURTH QUARTER OPERATING INCOME OF $14.2 MILLION; EX-ITEMS, $15.7 MILLION, DOWN 14% SEQUENTIALLY, UP 4% YEAR-OVER-YEAR FOURTH QUARTER OPERATING MARGINS, EX-ITEMS, OF 12% FOURTH QUARTER GAAP EPS OF $0.15; EX-ITEMS, $0.22, DOWN 12% SEQUENTIALLY, UP 16% YEAR-OVER-YEAR FOURTH QUARTER FREE CASH FLOW OF $16.2 MILLION, UP OVER 50% SEQUENTIALLY DEBT LEVERAGE RATIO REDUCED TO 1.31, AND NET DEBT REDUCED BY $11.7 MILLION COMPANY REPURCHASED 264,982 SHARES OF COMMON STOCK, A VALUE OF $4.9 MILLION, DURING THE FOURTH QUARTER COMPANY ANNOUNCES Q1 2025 QUARTERLY DIVIDENDFULL YEAR REVENUE OF $523.8 MILLION, UP 3%FULL

      1/29/25 5:15:00 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy

    $CLB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CAO & Treasurer Teo Sow Hang covered exercise/tax liability with 79 shares and converted options into 175 shares (SEC Form 4)

      4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)

      5/5/25 2:55:21 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • SVP, Gen Counsel & Secretary Tattoli Mark Damian covered exercise/tax liability with 178 shares and converted options into 450 shares, decreasing direct ownership by 1% to 16,072 units (SEC Form 4)

      4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)

      5/5/25 2:53:25 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • Director Temeng Kwaku converted options into 9,317 shares, increasing direct ownership by 57% to 25,528 units (SEC Form 4)

      4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)

      4/2/25 2:40:47 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy

    $CLB
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $CLB
    SEC Filings

    See more

    $CLB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • CORE LABORATORIES ANNOUNCES OPENING OF UNCONVENTIONAL CORE ANALYSIS LABORATORY IN SAUDI ARABIA

      HOUSTON, May 7, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") is pleased to announce the opening of its new Unconventional Core Analysis Laboratory in Dammam, Kingdom of Saudi Arabia. This state-of-the-art facility, developed in collaboration with Core's long-time partner, Abdulla Fouad Group, underscores the Company's commitment to advancing reservoir evaluation technologies in the Middle East. The Company's new analytical laboratory is equipped with advanced proprietary instrumentation designed to provide comprehensive core and fluid analysis services tailored to unconventional reservoirs. By bringing Core Lab's cutting-edge technologies t

      5/7/25 12:53:00 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • CORE LAB REPORTS FIRST QUARTER 2025 RESULTS

      REVENUE OF $123.6 MILLION, DOWN 4% SEQUENTIALLY AND 5% YEAR-OVER-YEAROPERATING INCOME OF $4.4 MILLION; EX-ITEMS, $11.8 MILLION, DOWN 25% SEQUENTIALLY AND 21% YEAR-OVER-YEAROPERATING MARGINS, EX-ITEMS, OF 10% GAAP EPS OF $0.00; EX-ITEMS, $0.14, DOWN 35% SEQUENTIALLY, AND 25% YEAR-OVER-YEARFREE CASH FLOW OF $3.9 MILLION, UP OVER 50% YEAR-OVER-YEAR NET DEBT REDUCED BY $4.9 MILLION; DEBT LEVERAGE RATIO REMAINS AT 1.31 COMPANY REPURCHASED 131,598 SHARES OF COMMON STOCK, A VALUE OF $2.0 MILLION COMPANY ANNOUNCES Q1 2025 QUARTERLY DIVIDEND HOUSTON, April 23, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported first quarter 2025 revenue of $123,6

      4/23/25 5:15:00 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • CORE LABORATORIES ANNOUNCES TIMING OF FIRST QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL

      HOUSTON, March 24, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its first quarter 2025 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m. EST on April 24, 2025. Larry Bruno, Chairman and CEO, Chris Hill, CFO, and Gwen Gresham, SVP Corporate Development and Investor Relations, will discuss financial and operational results. An earnings press release will be issued after market close on April 23, 2025, and may be accessed through the Company's website at www.corelab.com. To register for the listen-only webcast, log on to www.corelab.com at least fifteen minutes prior to the start of the call. For those not available to listen to the live webcast, a replay

      3/24/25 4:15:00 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • SEC Form 10-Q filed by Core Laboratories Inc.

      10-Q - Core Laboratories Inc. /DE/ (0001958086) (Filer)

      4/25/25 6:36:23 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • Core Laboratories Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Core Laboratories Inc. /DE/ (0001958086) (Filer)

      4/23/25 4:41:18 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • SEC Form DEFA14A filed by Core Laboratories Inc.

      DEFA14A - Core Laboratories Inc. /DE/ (0001958086) (Filer)

      3/31/25 4:59:20 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • Core Labs upgraded by Citigroup with a new price target

      Citigroup upgraded Core Labs from Sell to Neutral and set a new price target of $16.00 from $15.00 previously

      3/12/25 7:22:24 AM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • Core Labs downgraded by Citigroup with a new price target

      Citigroup downgraded Core Labs from Neutral to Sell and set a new price target of $21.00 from $22.00 previously

      6/30/23 7:19:53 AM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • Core Labs downgraded by BofA Securities with a new price target

      BofA Securities downgraded Core Labs from Neutral to Underperform and set a new price target of $21.50

      4/18/23 9:05:50 AM ET
      $CLB
      Oilfield Services/Equipment
      Energy